A review of the progress of COVID-19 vaccine development

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216305%3A26210%2F21%3APU140633" target="_blank" >RIV/00216305:26210/21:PU140633 - isvavai.cz</a>

Výsledek na webu

<a href="https://dergipark.org.tr/en/pub/dtfd/issue/60535/890089" target="_blank" >https://dergipark.org.tr/en/pub/dtfd/issue/60535/890089</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.18678/dtfd.890089" target="_blank" >10.18678/dtfd.890089</a>

Jazyk výsledku

angličtina

Název v původním jazyce

A review of the progress of COVID-19 vaccine development

Popis výsledku v původním jazyce

A coronavirus disease pandemic (COVID-19) is still a global problem with not sufficient evidence of a declining pattern caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It is generally accepted that normal life is impeded by securing a reliable vaccine strategy. Many countries have accelerated the process of clinical trials to create effective treatment with COVID-19. More than 200 candidate vaccines have been started for SARS-CoV-2 testing. This review attempts to provide an overview of the currently emerging COVID-19 vaccine types, address the theoretical and practical challenges of vaccines for COVID-19 and discuss possible strategies to help vaccine design succeed. The first move was to take out papers using the initial keyword “pandemics, vaccines and vaccine types”. A total of 63,538 results (including 1,200 journals; 16,875 books; and 12,871 web pages), with the initial keyword, searched for in the Scopus database. Further improvements were searched on keywords such as “pandemic and vaccine types” (711 newspapers and 5,053 webpages). This review attempts to overview the historical and important basic information about the pandemics viz. history, virological characteristics, structure, origin and physio-chemical properties. The second phase includes the vaccination types and strategies in depth. It includes the diagnosis, virology and pathogenesis of SARS-CoV-2 and SARS-COV-2/COVID-19 vaccines. The development, planning strategies, types, cost and current scenarios of COVID-19 vaccines are depicted in detail. The pandemic COVID-19 as it continues, is a global problem. Vaccination seems to be an efficient and economical way to mitigate and control the epidemic. This requires a mass production of successful COVID-19 vaccines. © 2021, Duzce University Medical School. All rights reserved.

Název v anglickém jazyce

A review of the progress of COVID-19 vaccine development

Popis výsledku anglicky

A coronavirus disease pandemic (COVID-19) is still a global problem with not sufficient evidence of a declining pattern caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It is generally accepted that normal life is impeded by securing a reliable vaccine strategy. Many countries have accelerated the process of clinical trials to create effective treatment with COVID-19. More than 200 candidate vaccines have been started for SARS-CoV-2 testing. This review attempts to provide an overview of the currently emerging COVID-19 vaccine types, address the theoretical and practical challenges of vaccines for COVID-19 and discuss possible strategies to help vaccine design succeed. The first move was to take out papers using the initial keyword “pandemics, vaccines and vaccine types”. A total of 63,538 results (including 1,200 journals; 16,875 books; and 12,871 web pages), with the initial keyword, searched for in the Scopus database. Further improvements were searched on keywords such as “pandemic and vaccine types” (711 newspapers and 5,053 webpages). This review attempts to overview the historical and important basic information about the pandemics viz. history, virological characteristics, structure, origin and physio-chemical properties. The second phase includes the vaccination types and strategies in depth. It includes the diagnosis, virology and pathogenesis of SARS-CoV-2 and SARS-COV-2/COVID-19 vaccines. The development, planning strategies, types, cost and current scenarios of COVID-19 vaccines are depicted in detail. The pandemic COVID-19 as it continues, is a global problem. Vaccination seems to be an efficient and economical way to mitigate and control the epidemic. This requires a mass production of successful COVID-19 vaccines. © 2021, Duzce University Medical School. All rights reserved.

Druh

J_SC - Článek v periodiku v databázi SCOPUS

CEP obor

—

OECD FORD obor

20704 - Energy and fuels

Projekt

<a href="/cs/project/EF15_003%2F0000456" target="_blank" >EF15_003/0000456: Laboratoř integrace procesů pro trvalou udržitelnost</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2021

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Duzce Medical Journal

ISSN

1307-671X

e-ISSN

—

Svazek periodika

23

Číslo periodika v rámci svazku

1

Stát vydavatele periodika

TR - Turecká republika

Počet stran výsledku

23

Strana od-do

1-23

Kód UT WoS článku

—

EID výsledku v databázi Scopus

2-s2.0-85103410990